Eric Batill, the General Counsel of $CHPT, sold 2,976 shares of the company on 12-23-2025 for an estimated $20,784. We received data on the trade from a recent SEC filing. This was a sale of approximately 3.5% of their shares of this class of stock. Following this trade, they now own 81,305 shares of this class of $CHPT stock.
$CHPT Insider Trading Activity
$CHPT insiders have traded $CHPT stock on the open market 8 times in the past 6 months. Of those trades, 0 have been purchases and 8 have been sales.
Here’s a breakdown of recent trading of $CHPT stock by insiders over the last 6 months:
- JAGDEEP CA SINGH (CCXO) has made 0 purchases and 2 sales selling 6,535 shares for an estimated $52,949.
- ERIC BATILL (General Counsel) has made 0 purchases and 2 sales selling 5,034 shares for an estimated $43,980.
- MANSI KHETANI (CFO) has made 0 purchases and 2 sales selling 5,245 shares for an estimated $42,220.
- JOHN DAVID VICE (CRO) has made 0 purchases and 2 sales selling 3,282 shares for an estimated $33,059.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$CHPT Hedge Fund Activity
We have seen 114 institutional investors add shares of $CHPT stock to their portfolio, and 46 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- VANGUARD GROUP INC added 1,033,854 shares (+inf%) to their portfolio in Q3 2025, for an estimated $11,289,685
- BLACKROCK, INC. added 496,387 shares (+inf%) to their portfolio in Q3 2025, for an estimated $5,420,546
- MILLENNIUM MANAGEMENT LLC added 290,013 shares (+inf%) to their portfolio in Q3 2025, for an estimated $3,166,941
- CATALYST FUNDS MANAGEMENT PTY LTD removed 229,400 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $2,505,048
- GEODE CAPITAL MANAGEMENT, LLC added 211,930 shares (+inf%) to their portfolio in Q3 2025, for an estimated $2,314,275
- INVESCO LTD. added 175,327 shares (+inf%) to their portfolio in Q3 2025, for an estimated $1,914,570
- CITADEL ADVISORS LLC added 155,218 shares (+inf%) to their portfolio in Q3 2025, for an estimated $1,694,980
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$CHPT Revenue
$CHPT had revenues of $98.6M in Q2 2026. This is a decrease of -9.17% from the same period in the prior year.
You can track CHPT financials on Quiver Quantitative's CHPT stock page.
$CHPT Analyst Ratings
Wall Street analysts have issued reports on $CHPT in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Benchmark issued a "Buy" rating on 09/05/2025
To track analyst ratings and price targets for $CHPT, check out Quiver Quantitative's $CHPT forecast page.
$CHPT Price Targets
Multiple analysts have issued price targets for $CHPT recently. We have seen 8 analysts offer price targets for $CHPT in the last 6 months, with a median target of $9.5.
Here are some recent targets:
- Jon Windham from UBS set a target price of $9.0 on 12/22/2025
- Ryan Pfingst from B. Riley Securities set a target price of $11.0 on 12/10/2025
- Mark Delaney from Goldman Sachs set a target price of $10.0 on 12/08/2025
- Christopher Dendrinos from RBC Capital set a target price of $9.0 on 12/05/2025
- Craig Irwin from Roth Capital set a target price of $8.5 on 12/05/2025
- Mickey Legg from Benchmark set a target price of $20.0 on 09/05/2025
- Bill Peterson from JP Morgan set a target price of $8.0 on 09/04/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
